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Abstract
A number of authors have studies the mixture survival model to analyze survival
data with nonnegligible cure fractions. A key assumption made by these authors
is the independence between the survival time and the censoring time. To our
knowledge, no one has studies the mixture cure model in the presence of de-
pendent censoring. To account for such dependence, we propose a more general
cure model which allows for dependent censoring. In particular, we derive the
cure models from the perspective of competing risks and model the dependence
between the censoring time and the survival time using a class of Archimedean
copula models. Within this framework, we consider the parameter estimation,
the cure detection, and the two-sample comparison of latency distribution in the
presence of dependent censoring when a proportion of patients is deemed cured.
Large sample results using the martingale theory are obtained. We applied the
proposed methodologies to the SEER prostate cancer data.
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1 Introduction
Survival models incorporating a cure fraction, often termed as cure rate models, have emerged as
a powerful statistical tool for analyzing cancer studies. Applications have been found in modeling
time-to-event data for a variety of cancers, including prostate cancer, breast cancer, non-Hodgkins
lymphoma, leukemia, melanoma, and head and neck cancer, where for these diseases, a signicant
proportion of patients are \cured" after therapies. By cure it is meant that an individual will have
little or no risk of experiencing the event of interest, e.g. death from breast cancer. Recent years
have seen a spurt in statistical literature that deals with survival data with a nonnegligible cure
fraction; see e.g. Kuk and Chen (1992), Maller and Zhou (1996), Peng and Dear (2000), Sy and
Taylor (2000), among others. Most of the current work stems from the mixture model originally
proposed by Boag (1949) and Berkson and Gage (1952), which is formulated as follows.
Suppose T is the survival time, e.g. time from the diagnosis of prostate cancer, and U is the
potential random censoring time, e.g. study duration or cardiac failure, with only X = min(T;U)
and censoring indicator Æ = I(X = T ) observed in practice. Denote by F
T
(t) = P (T  t); F
U
(t) =
P (U  t) the cumulative distribution functions, and S
T
(t) = P (T > t); S
U
(t) = P (U > t); the
survival functions, for T and U , respectively. The scientic research often centers on discerning
F
T
(t) while treating F
U
(t) as nuisance.
The mixture cure model assumes F
T
to be an improper distribution over the entire real line
and species
F
T
(t) = pF
0
(t); (1)
or, equivalently,
S
T
(t) = 1  p+ pS
0
(t); (2)
where 0 < p < 1, S
0
(t) = 1 F
0
(t), and F
0
(t) is a proper distribution such that lim
t!1
F
0
(t) = 1.
Models (1) and (2) consider the study population as an unobservable mixture of patients deemed
susceptible (non-cured) and non-susceptible (cured) . Note that (1 p) corresponds to the fraction
of cured, that is, the point mass that T puts on 1 and F
0
(t) is the distribution for the non-cured
patients, often termed as the latency distribution.
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A key assumption made by the current literature is the independence between the survival time
T and the censoring time U . To our knowledge, none has studied the mixture cure model in the
presence of dependent censoring, which are commonly observed in biological studies. For example,
in the prostate cancer data set of the NIH Surveillance Epidemiology and End Results (SEER) pro-
gram, a proportion of patients diagnosed with this type of cancer died from heart/cardiovascular
diseases. A recent study (see http://www.thewbalchannel.com/healtharchive/4161401/detail.html)
has revealed that the prostate cancer and the cardiovascular disease may be linked through a com-
mon risk factor, high cholesterol. Therefore, it would seem implausible to assume independence
between the main endpoint (e.g. deaths from prostate cancer) and the censoring causes (e.g.
deaths from heart diseases). In this paper, we propose a more general cure model which allows
for dependent censoring. In particular we derive the mixture cure model from perspectives of com-
peting risks and model the dependence between the censoring time and the survival time using a
class of Archimedean copula models. Within this framework, we focus on the cure detection, and
the comparison of latency distributions in the presence of dependent censoring when a proportion
of patients is deemed cured.
The rest of the article is structured as follows. In Section 2 we introduce a mixture cure model
with the dependence of the censoring and survival times modeled by a class of Archimedean copula
models. We also derive an estimator for estimating the survival function and the cure fraction
with dependent censoring. In Section 3 we show the consistency of the estimator, and in Section 4
we test for suÆcient follow up, a suÆcient condition for consistently estimating the cure fraction.
We prove the asymptotic normality in Section 5 and conduct the hypothesis testing in Section 6.
We conclude this article with discussion and future work in Section 7. We defer all the proofs to
the Appendix.
2 Mixture Cure Model with Archimedean Dependence
Throughout we assume that the survival time T follows the mixture model (1), or, equivalently,
(2). Denote the joint survival of the failure and censoring times by C(t; u) = P (T > t; U > u).
2
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An Archimedean copula model links the marginal survivals of T and U through
C(t; u) = 
 1
[fS
T
(t)g+ fS
U
(u)g]; (3)
where a nonincreasing function  : [0; 1] ! [0;1] is specied such that (1) = 0 and (0) = 1.
Examples include (t) =   log t, corresponding to independent censoring, the family of Clay-
ton's models with (t) = (t
 a
  1)=a (for a > 0), and the Frank family with (t) =   log((1  
exp( at))=(1  exp( a)) (for a > 0). We adopt the Archimedean copula formulation to empha-
size the functional independence of the parameterizations of the marginal distribution functions,
governed by S
T
and S
U
, and the dependence structure, governed by a class of copula functions
. This formulation also facilitates a derivation of the estimator for S
T
, our main interest.
Suppose that we observe n i.i.d data, (X
i
; Æ
i
); i = 1; : : : ; n and consider the counting processes
N
i
(t) = I(X
i
 t; Æ
i
= 1) and the at-risk processes Y
i
(t) = I(X
i
 t). Denote by N(t) =
P
N
i
(t)
and Y (t) =
P
Y
i
(t). Introduce the ltration
F
n
t
= fN
i
(s); Y
i
(s+); 0  s  t; i = 1; : : : ; ng;
which contains the survival information up to time t for all n subjects and to which all the ensuing
martingales and stopping times adapt. We denote the survival function for the observed times X
i
by (t) = P (X
i
> t) = C(t; t).
The following heuristically discusses an estimator based on (3), whose large sample properties
will be considered in the next section. Denote by
^
S
T
and
^
S
U
the estimates for S
T
and S
U
respec-
tively, which are right continuous and piecewise constant functions with jumps only occurring at
the observed failures and censorings, respectively. Denote by ^(t) the empirical estimate of (t),
which is
^(t) =
X
i
I(X
i
> t)=n = Y (t+)=n:
By (3), at each observed time points X
i
, i=1, . . . , n,
f
^
S
T
(X
i
)g+ f
^
S
U
(X
i
)g = f^(X
i
)g:
Assume that P (T = U) = 0 (i.e. the censoring and failure cannot occur at the same time almost
surely). Then at each observed failure time point X
i
(such that Æ
i
= 1), we have
^
S
U
(X
i
 ) =
3
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^S
U
(X
i
) and
(
^
S
T
(X
i
))  (
^
S
T
(X
i
 )) = (^(X
i
))  (^(X
i
 ))
= 

Y (X
i
)
n
 
1
n

  

Y (X
i
)
n

: (4)
Applying (4) recursively, we write the estimate
^
S
T
in the form of counting process as follows
^
S
T
(t) = 
 1

Z
t
0
I(Y (s) > 0)



Y (s)
n
 
1
n

  

Y (s)
n

dN(s)

; (5)
which corresponds to the estimator derived by Rivest and Wells (2001) in the absence of cure
fraction. When computing (5), we invoke the convention of 0=0 = 0 if necessary.
It is obvious that
^
S
T
(t) is nonincreasing and is a constant when t  max
Æ
i
=1
fX
i
g = X
n
, the
largest observed failure time. In addition this constant is nonzero when the largest value among
all the observed times (X
1
; : : : ;X
n
), denoted by X
n
= sup
t
ft : Y (t) > 0g, is censored. Under
some regularity conditions, we will explore using this constant to estimate the cure fraction and
to study the asymptotic properties.
Before proceeding further, introduce the right extremes 
F
0
= sup
t
ft : F
0
(t) < 1g, 
U
=
sup
t
ft : F
U
(t) < 1g and 
X
= sup
t
ft : (t) > 0g. From (1), it follows that 
F
0
= sup
t
ft : F
T
(t) <
pg = sup
t
ft : S
T
(t) > 1  pg. Throughout, denote by a ^ b = min(a; b) and a _ b = max(a; b) for
two real numbers a and b.
Our main results are as follows: under some regularity conditions (listed in Appendix A.0)
 The cure fraction can be consistently estimated based on
^
S
T
. Specically,
^
S
T
(X
n
)
pr:
! 1  p,
or, equivalently,
^
F
T
(X
n
)
pr:
! p.
 The estimate of the cure fraction is asymptotically normally distributed. That is,
p
nf
^
F
T
(X
n
) 
pg or equivalently,
p
nf
^
S
T
(X
n
)  (1  p)g converges in distribution to a mean zero normal
random variable with a nite variance.
 The estimate of the latency distribution is uniformly consistent and asymptotically nor-
mal. More specically, sup
t2[0;
X
]



^
F
T
(t)
^
F
T
(X
n
)
  F
0
(t)



pr:
! 0; and
p
n
n
^
F
T
(t^X
n
)
^
F
T
(X
n
)
  F
0
(t ^X
n
)
o
converges weakly to a tight Gaussian process on the Skorohod space D[0; 
X
].
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We will further consider cure detection and propose a class of tests for testing the equality
of the latency distribution F
0
in a two-sample comparison setting along the lines of Li and Feng
(2005).
3 Consistency
Introduce the crude hazard function dened by
d
~
(t) =
~
(t)dt = P (t < T  t+ dtjT > t; U > t);
along with the martingale processes
M
i
(t) = N
i
(t) 
Z
t
0
Y
i
(s)d
~
(t):
Our later development relies heavily on the fact thatM
i
(t) are square integrable martingales with
respect to ltration F
n
t
even when the survival time T and the censoring time U are dependent
(Fleming and Harrington, 1991, Theorem 1.3.1). Note that when T and U are dependent the
crude hazard
~
(t) may not be equal to the conventional hazard dened by (t) =
1
dt
P (t < T 
t + dtjT > t). For example, consider a Clayton joint survival C(t; u) = (e
a
1
t
+ e
a
2
u
  1)
 
1
a
,
which corresponds to the Archimedean copula model with (t) = (t
 a
  1)=a and S
T
(t) = e
 
1
t
and S
U
(u) = e
 
2
u
, where a  0; 
1
> 0 and 
2
> 0. It follows that the crude hazard
~
(t) = 
1
e
a
1
t
e
a
1
t
+ e
a
2
t
  1
;
which diers from the conventional hazard 
1
when a 6= 0. Other counter-examples can be found
in Example 1.3.1 of Fleming and Harrington (1991).
Under the regularity conditions ( (c.1)-(c.5) listed in Appendix A.0) on S
T
(t) (or F
T
(t)), (t)
and the copula function , the following proposition states that
^
S
T
(t) is a uniformly consistent
estimator to S
T
(t).
Proposition 1 (
^
S
T
(t)) converges to (S
T
(t)) uniformly on [0; 
X
]. Moreover,
^
S
T
(t) converges
to S
T
(t) uniformly on [0; 
X
] and the Nelson-Aalen estimator
R
t
0
I(Y (s) > 0)
dN(s)
Y (s)
converges to
~
(t) in probability uniformly on [0; 
X
].
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Note that in this proposition we allow (
X
) = 0. That is, we consider the convergence over
the entire support of the distribution of X, a useful result for the cure detection in our later
development and a stronger result than Theorem 1 of Rivest and Wells (2001) in the absence of
cure.
In addition, a byproduct of this proposition is the feasibility of consistently estimating an
important parameter P (T  U), which is the probability of observing death from a particular
cancer prior to censoring. Indeed,
P (T  U) =
Z
1
0
P (T 2 (t; t+ dt]; U > t)
=
Z
1
0
(t)P (T 2 (t; t+ dt]; U > tjT > t; U > t)
=
Z
1
0
(t)d
~
(t):
Proposition 1 indicates that the Nelson-Aalen estimator
R
t
0
I(Y (u) > 0)dN=Y consistently
estimates
~
(t). Hence a natural `plug-in' estimator for P (T  U)
def
= P is
^
P =
Z
1
0
Y (u)
n
I(Y (u) > 0)
dN
Y
=
Z
1
0
I(Y (u) > 0)
1
n
dN 
Z
1
0
1
n
dN =
1
n
n
X
i
Æ
i
:
A simple martingale argument shows that
^
P consistently estimates P . Since Æ
i
are independent
Bernouli random variables, the central limit theorem leads to
p
n(
^
P   P )
d
! N(0; P (1  P ));
and one simply approximates the variance of
^
P by
^
P (1 
^
P )=n.
It is natural to use the plateau of the estimated survival curve
^
S
T
(X
n
) to estimate the cure
fraction (1  p). The following two propositions indicate this approach is proper if and only if the
support of the latency distribution is covered by that of the censoring distribution.
Proposition 2
^
S
T
(X
n
)
pr:
! (1  p) if and only if 
F
0
 
X
:
As 
X
characterizes the support ofX = T^U , we can further show that 
X
= 
U
in the presence
of cure under model (3). That is, the supports of X and U coincide under an Archimedean model
when the cure fraction is non zero.
Proposition 3 When 0 < p < 1, 
X
= 
U
under (3).
6
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4 Testing SuÆcient Follow-up
Propositions 2 and 3 indicate that when p < 1, it will be consistently estimated by 1 
^
S
T
(X
n
) if

F
0
< 
U
, that is, if the right extreme of the censoring distribution S
U
exceeds that of the latency
distribution F
0
. Even when p = 1, similar proofs will show that 1 
^
S
T
(X
n
) consistently estimates
p = 1 provided 
F
0
< 
U
. Thus even in the absence of cure fraction, (5) provides a consistent
estimate for p and we will not be misled by using (5) as long as 
F
0
< 
U
, reecting a suÆcient
follow-up.
Therefore it is crucial to test the hypothesis 
F
0
< 
U
for consistently estimating (1   p) by
using (5). Applying the Borel-Cantelli lemma, we can show X
n
, the largest observed failure
time, ! 
F
0
^ 
U
almost surely, while X
n
, the largest observed time (which may be censored), is
arbitrarily close to 
U
, that is, X
n
! 
U
almost surely. Hence, if 
F
0
^ 
U
< 1, X
n
  X
n
!

U
  
F
0
almost surely if 
F
0
< 
U
, and converges to 0 almost surely if 
F
0
 
U
. Thus a large
value of X
n
  X
n
gives evidence to H
a
: 
F
0
< 
U
while a small value of X
n
  X
n
points to
H
0
: 
F
0
 
U
. Based on X
n
 X
n
and following Maller and Zhou (1992, 1994) we consider the
test statistic

n
= (1 N
n
=n)
n
where N
n
is the number of failures observed in [2X
n
  X
n
;X
n
]. One accepts H
a
when 
n
is suÆciently small, e.g. 
n
< 0:05 (or N
n
is suÆciently large), while accepting H
0
when 
n
is
suÆciently large, e.g. 
n
> 0:05 (or N
n
is suÆciently small). The heuristics, along with a detailed
derivation, of this test when T and U are independent is given in Maller and Zhou (1994).
Denote by 

= 
F
0
^ 
U
and dene an increasing function h(a) =
R




 a
(t)d
~
(t). We impose
more regularity conditions on function h. Specically, we suppose that there exists a small 
0
> 0
(if 
F
0
< 
U
, we require 
0
< 
U
  
F
0
) such that
(d.1) h(a) is continuous on [0; 
0
].
(d.2) (dominated variation) there exists an M > 0 such that 0 < h(2a) < Mh(a) for any a 2
7
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(0; 
0
]; or, equivalently,
lim sup
a!0+
h(a)
h(a)
<1 (6)
for all  > 0 (see, e.g. Bingham et al. (1987)).
We rst comment on the condition (d.2), which characterizes the behavior of h near 0, and show
that it holds under general circumstances. In fact, when 
F
0
< 
U
, we have (

) = (
F
0
^
U
) > 0.
Hence, (6) reduces to
lim sup
a!0+
~
(

) 
~
(

  a)
~
(

) 
~
(

  a)
<1;
which would be true, if we assume
~

(k)
(

 ) 6= 0 for some positive integer k, by a Taylor expan-
sion. When 
F
0
 
U
, we can apply L'Hopital's rule on (6). Then (6) reduces to
lim sup
a!0+
(

  a)
~

0
(

  a)
(

  a)
~

0
(

  a)
<1;
which again holds widely if both (t) and
~
 have nite nonzero derivatives of some order at 
 
.
Hence, (6) essentially requires that (t) and
~
 have `mild' changes near 

and thus is expected
to hold for most commonly assumed distributions.
We now show such a test is consistent when T and U are dependent through model (3) and
under the regularity conditions (d.1) and (d.2). The proof is along the line of Maller and Zhou
(1994) and can be found in Appendix A.4.
Proposition 4 That 
n
! 0 in probability if and only if 
F
0
< 
U
.
One would expect that the type of test developed above in the spirit of Maller and Zhou
(1994) would display a monotonic behavior. That is, the longer the duration of study, the more
likely suÆcient it is for making inferences about the cure rates. Klebanov and Yakovlev (2005),
however, have shown that with the nite samples Maller and Zhou's test may behave unstably and
non-monotonically even when the duration increases. They were less concerned with estimating
the cure proportion consistently and proposed to forgo the test of 
F
0
< 
U
. Instead, they focused
solely on testing the existence of cure fraction, which, to us, is of interest in its own merit. We
will pursue this idea in the presence of dependent censoring in Section 6.
8
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5 Asymptotic Normality
So far we have established the consistency of the estimator when the support of the latency
distribution is fully covered by the censoring. To avoid technicality, we assume that 
F
0
< 
U
in the
ensuing developments and show that the proposed estimator for cure fraction is also asymptotically
normal.
Dene the stopped process
Z
n
(t) =
p
nf(
^
S
T
(t ^X
n
))  (S
T
(t ^X
n
))g: (7)
and the covariance function
C(t
1
; t
2
) =
Z
t
1
^t
2
0
(s)(
0
((s)))
2
d
~
(s) + 2
Z
t
1
^t
2
0
Z
s
0
(s)(1  (u)) 
0
((u)) 
0
((s))d
~
(u)d
~
(s)
+2
Z
t
1
^t
2
0
Z
s
0

0
((u))(s) 
0
((s))d
~
(u)d
~
(s)
+
Z
t
1
_t
2
t
1
^t
2
(s) 
0
((s))d
~
(s)
Z
t
1
^t
2
0

f1  (u)g 
0
f(u)g+ 
0
f(u)g

d
~
(u) (8)
for 0  t
1
; t
2
; < 
X
, where  (s)
def
=  s
0
(s). From Proposition 1, this covariance function can
be consistently estimated by replacing (s) and d
~
(u) with their empirical counterparts, ^(s)
andI(Y (u) > 0)dN(u)=Y (u) respectively. Denote the variance function v
0
(t) = C(t; t), which
coincides with the variance function obtained by Rivest and Wells (note there are two typographic
errors in their formula). Assume that lim
t!
X
v
0
(t) = v
1
0
<1 and C
1
(t)
def
= lim
v!
X
C(v; t) <1
for every t 2 [0; 
X
).
Proposition 5 Z
n
(t) converges weakly to I[0; 
X
)Z(t) + If
X
gZ
1
on D[0; 
X
], where Z(t) is a
tight Gaussian process with the covariance function C(t
1
; t
2
) and Z
1
is a normal random variable
with the variance v
1
0
and covfZ
1
; Z(t)g = C
1
(t).
Denote by p^ = 1  
^
S
T
(X
n
). We are now ready to show the asymptotic normality of p^, the
estimator for the cure fraction.
Proposition 6 Assume that 0 < p < 1 and
lim
t!
F
0
1  F
0
(t)
(t)
< 1: (9)
9
http://biostats.bepress.com/harvardbiostat/paper26
Then we have
p
nf(1  p^)  (1  p)g
d
! Z
1
; (10)
where Z
1
is a mean 0 normal random variable with variance v
1
0
= lim
t!
X
v
0
(t). Furthermore,
p
n(p^  p)
d
!
Z
1
 
0
(1  p)
: (11)
Once we have identied the cure proportion we shall be able to compute the estimate for the
latency distribution as follows
^
F
0
(t) =
^
F
T
(t)
p^
=
1 
^
S
T
(t)
p^
:
The following two propositions concerns the large sample results for this estimator.
Proposition 7 For 0 < p < 1,
sup
[0;
X
]
j
^
F
0
(t)  F
0
(t)j
pr:
! 0:
Proposition 8 Let 
X
= supft : (t) > 0g. Then
p
nf
^
F
0
(t ^X
n
)  F
0
(t ^X
n
)g
w
! G(t)
on a Skorohod space D[0; 
X
], where G(t) =  
Z(t)
p
0
(S
T
(t))
+
Z
1
f1 S
T
(t)g
p
2

0
(1 p)
and Z(t) and Z
1
are dened
as in Proposition 5.
Note that if we replace the largest observed time X
n
by the largest observed failure time
X
n
, in the estimator (1   p^) =
^
S
T
(X
n
), all the large sample results hold. This follows as
Pf
^
S
T
(X
n
) =
^
S
T
(X
n
)g = 1 by the denition of
^
S
T
.
6 Hypothesis Testing
6.1 Testing the Existence of Cure Fraction
A natural question arising from cure modeling is whether the cure fraction exists. Hence, testing
p < 1 is of substantial interest. In the following we derive a test for testing H
0
: p = 1 against
H
a
: p < 1 by extending Klebanov and Yakovlev's test to the situation of dependent censoring.
The derivations come at a small price by assuming the underlying hazard for non-cured patients
10
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is a monotone function of time, a plausible assumption in most biological studies, as opposed to
the restrictive non-decreasing hazard assumption made by Klebanov and Yakovlev (2005).
Under the mixture model (2), H
0
is equivalent to H
0
0
: max
0<t<
X
fS
T
(t)  S
0
(t)g = 0. For a
given data, our idea is to compute the 1  condence interval for the dierence  = max
t
fS
T
(t) 
S
0
(t)g and to reject H
0
0
at the  level. Klebanov and Yakovlev considered H
00
0
: S(t
1
) S
0
(t
1
) = 0,
where t
1
is a prespecied constant. Though H
0
0
and H
00
0
are essentially equivalent, a data driven
choice of t
1
, which magnies the dierence between these two survival functions, allows us to
increase the power of the proposed test while controlling the signicance level.
We rst assume that the hazard 
0
(t) =  d=dt logS
0
(t) is a non-decreasing function in t,
implying that   log S
0
(t)=t is a non-decreasing function. Hence, for any t
1
 t
0
> 0,
  log S
0
(t
1
)
t
1

  logS
0
(t
0
)
t
0
or,
S
0
(t
1
)  (S
0
(t
0
))
t
1
=t
0
 (S
T
(t
0
))
t
1
=t
0
(12)
and from (2),
S
T
(t
1
)  1  p+ p(S
T
(t
0
))
t
1
=t
0
:
Therefore, we obtain an upper bound for p
p 
1  S
T
(t
1
)
1  S
T
(t
0
))
t
1
=t
0
:
Since t
0
and t
1
is arbitrary,
p  min
0<t
0
<t
1
<
X
1  S
T
(t
1
)
1  fS
T
(t
0
)g
t
1
=t
0
def
= ~p
Because of the uniform consistency of
^
S
T
(Proposition 1) and the almost sure convergence of X
n
to 
X
, ~p can be consistently estimated by the statistic
b
~p = minf min
0<t
0
<t
1
<X
n
1 
^
S
T
(t
1
)
1  f
^
S
T
(t
0
)g
t
1
=t
0
; 1g: (13)
From (12), we have
S
T
(t
1
)  S
0
(t
1
)  S
T
(t
1
)  (S
T
(t
0
))
t
1
=t
0
def
= (t
0
; t
1
);
11
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for any xed 0 < t
0
< t
1
. Our goal is to construct an asymptotic (1   ) condence interval for
(t
0
; t
1
) based on Proposition 5 and leave aside the question of choosing t
0
; t
1
for now.
To apply proposition 5, we consider the truncated version of S
T
and its estimator
^
S
T
. Since
X
n
! 
X
almost surely, the following inequality holds with probability 1 for any 0 < t
0
< t
1
< 
X
S
T
(t
1
^X
n
)  S
0
(t
1
^X
n
)  S
T
(t
1
^X
n
)  (S
T
(t
0
^X
n
))
t
1
=t
0
def
=
^
(t
0
; t
1
);
and
^
(t
0
; t
1
)! (t
0
; t
1
) almost surely.
Consider
^
(t
0
; t
1
) =
^
S
T
(t
1
^X
n
)  (
^
S
T
(t
0
^X
n
))
t
1
=t
0
+fS
T
(t
1
^X
n
) 
^
S
T
(t
1
^X
n
)g   f(S
T
(t
0
^X
n
))
t
1
=t
0
 
^
S
T
(t
0
^X
n
))
t
1
=t
0
g:
Using a Taylor expansion, we have
j(
^
S
T
(t
0
^X
n
))
t
1
=t
0
  (S
T
(t
0
^X
n
))
t
1
=t
0
j =
t
1
t
0

t
1
=t
0
 1
n
j
^
S
T
(t
0
^X
n
)  S
T
(t
0
^X
n
)j;
where 
n
is between
^
S
T
(t
0
^X
n
) and S
T
(t
0
^X
n
). Proposition 1 then immediately implies that

n
p
! S
T
(t
0
). Hence with a probability going to 1,
j(
^
S
T
(t
1
^X
n
))
t
1
=t
0
 (S
T
(t
1
^X
n
))
t
1
=t
0
j  (1+
0
)
t
1
t
0
S
T
(t
0
)
t
1
=t
0
 1
j
^
S
T
(t
1
^X
n
) S
T
(t
1
^X
n
)j; (14)
where 
0
is any xed positive number.
Also, the weak convergence of
p
nf
^
S
T
( ^ X
n
)   S
T
( ^ X
n
)g, coupled with the continuous
mapping theorem, gives
P (
p
n sup
t
j(
^
S
T
(t ^X
n
)  S
T
(t ^X
n
)j  D

)! 1  ; (15)
where D

is the upper   100 percentile of sup
t
jZ(t)=
0
(S
T
(t))j (based on Proposition 5).
Then, we have the following asymptotic lower condence limit for (t
0
; t
1
), and hence, for
 = sup
0<t<
X
fS
T
(t)  S
0
(t)g (which is larger than
^
(t
0
; t
1
)) almost surely). More specically,
some basic probabilistic arguments lead to (when n is suÆciently large)
P (  L
n
) = P (
^
(t
0
; t
1
)  L
n
)  1  ; (16)
12
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where
L
n
=
^
S
T
(t
1
^X
n
)  (
^
S
T
(t
0
^X
n
))
t
1
=t
0
  (1 +
t
1
t
0
(1 + 
0
)(S
T
(t
0
))
t
1
=t
0
 1
)D
=2
=
p
n (17)
Since (16) holds true for any 
0
> 0, we may let 
0
! 0 in (17). In practice, the lower bound would
be obtained by replacing the unknown S
T
(t
0
) in (17) with its consistent estimate
^
S
T
(t
0
^X
n
).
If the hazard 
0
(t) =  d=dt logS
0
(t) is a non-increasing function of t, similar arguments lead
to S
0
(t
0
)  (S
T
(t
1
))
t
0
=t
1
for any t
0
 t
1
and that the upper bound for p is
~p
def
= min
0<t
0
<t
1
<
X
1  S
T
(t
0
)
1  fS
T
(t
1
)g
t
0
=t
1
which can be consistently estimated by the statistic
b
~p = minf min
0<t
0
<t
1
<X
n
1 
^
S
T
(t
0
)
1  f
^
S
T
(t
1
)g
t
0
=t
1
; 1g: (18)
In view of S
T
(t
0
)  S
0
(t
0
)  S
T
(t
0
)  (S
T
(t
1
))
t
0
=t
1
, we redene (t
0
; t
1
) such that
(t
0
; t
1
)
def
= S
T
(t
0
)  (S
T
(t
1
))
t
0
=t
1
and redene
^
(t
0
; t
1
)
def
= S
T
(t
0
^X
n
)  (S
T
(t
1
^X
n
))
t
0
=t
1
;
which can be written
^
(t
0
; t
1
) =
^
S
T
(t
0
^X
n
)  (
^
S
T
(t
1
^X
n
))
t
0
=t
1
+fS
T
(t
0
^X
n
) 
^
S
T
(t
0
^X
n
)g   f(S
T
(t
1
^X
n
))
t
0
=t
1
 
^
S
T
(t
1
^X
n
))
t
0
=t
1
g:
Using the Taylor expansion, we have (S
T
(t
1
^X
n
))
t
0
=t
1
 
^
S
T
(t
1
^X
n
))
t
0
=t
1
=
t
0
t
1

t
0
=t
1
 1
n
(S
T
(t
1
^
X
n
) 
^
S
T
(t
1
^X
n
)), where 
n
is between
^
S
T
(t
1
^X
n
) and S
T
(t
1
^X
n
). Proposition 1 then directly
implies that 
n
p
! S
T
(t
1
). Hence with a probability going to 1,
j(
^
S
T
(t
1
^X
n
))
t
0
=t
1
 (S
T
(t
1
^X
n
))
t
0
=t
1
j < (1+
0
)
t
0
t
1
S
T
(t
1
)
t
0
=t
1
 1
j
^
S
T
(t
1
^X
n
) S
T
(t
1
^X
n
)j; (19)
where 
0
is any xed positive number.
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If S
T
(t
1
) is close to 0, S
T
(t
1
)
t
0
=t
1
 1
may not be well bounded. However, notice, for any
constants 0  x; y; a  1, it is easy to show that jx
a
  y
a
j  jx  yj
a
. It follows that
j(
^
S
T
(t
1
^X
n
))
t
0
=t
1
  (S
T
(t
1
^X
n
))
t
0
=t
1
j  j
^
S
T
(t
1
^X
n
)  S
T
(t
1
^X
n
)j
t
0
=t
1
; (20)
as 0 < t
0
=t
1
< 1. Therefore, combining (19) and (20)gives
j(
^
S
T
(t
1
^X
n
))
t
0
=t
1
  (S
T
(t
1
^X
n
))
t
0
=t
1
j  minf(1 + 
0
)
t
0
t
1
S
T
(t
1
)
t
0
=t
1
 1
O
n
; O
t
0
=t
1
n
g;
where O
n
= sup j
^
S
T
(t ^X
n
)  S
T
(t ^X
n
)j.
Hence, using (15) and let 
0
! 0, we obtain that
P (  L
n
)  P (
^
(t
0
; t
1
)  L
n
)  1   (21)
where
L
n
=
^
S
T
(t
0
^X
n
) f
^
S
T
(t
1
^X
n
)g
t
0
t
1
 fD
=2
=
p
n+min(
t
0
t
1
^
S
T
(t
1
^X
n
)
t
0
=t
1
 1
D
=2
=
p
n; (D
=2
=
p
n)
t
0
t
1
)g:
If the lower end of the (1  ) condence interval in (16) or (21) (depending on whether 
0
() is
non-decreasing or non-increasing) is greater than 0, thenH
0
would be rejected at a signicant level
of less than . To increase the power, the choice of t
0
and t
1
can be data driven. In particular, they
can be chosen based on (13) or (18) (again depending on the monotonicity of 
0
()) to minimize
the upper bound of p. Indeed, that t
0
and t
1
in (16) or (21) are chosen by minizing the lower
bound of p (c.f. (13) or (18) ) does not aect the probabilistic arguments leading to (16) or (21)
because the latter limit is based on the Kolmogorov distance
p
n sup j
^
S
T
( ^X
n
)   S
T
( ^X
n
)j,
which is uniformly valid for all times t
1
; t
0
. Thus, the data driven t
1
; t
0
will allow us to increase
power while maintaining the proper signicant level.
6.2 Comparisons of Cure Fractions and Latency Distributions
If the presense of cure fraction is veried, it would also be of interest to compare the cure fractions
and study the latency distributions, for example, when evaluating the eÆcacy of treatments. We
consider below a two-treatment comparison scenario and adopt the notation used in the general
cure model, except that we use an additional subscript i to indicate the treatments. Specically,
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we denote the time-to-event variables and censoring times by T
ij
; U
ij
, i = 1; 2; j = 1; : : : ; n
i
; where,
for example, i = 1 corresponds to the control arm and i = 2 to the experimental arm, and j refers
to the j-th patient in his respective treatment arm. Let n = n
1
+ n
2
. We assume that n
1
=n! 
where  is a xed constant and 0 <  < 1. We further assume that the fT
ij
; U
ij
: i = 1; 2; j =
1; : : : ; n
i
g are all independent, but T
ij
; U
ij
can be dependent. Because of censoring, we only observe
X
ij
= T
ij
^ U
ij
and Æ
ij
= I(T
ij
 U
ij
). We assume that the joint survival of T
ij
; U
ij
follows an
Archimedean model. Dene the right extremes 
F
0;1
; 
F
0;2
; 
X;1
; 
X;2
. To apply the obtained large
sample results in the previous section, we assume that 
F
0;1
_ 
F
0;2
 
X;1
^ 
X;2
def
=  . That is,
[0;  ] fully covers the supports of both latency distributions.
We rst focus on the comparison of the cure fractions between the two treatment arms and
formulate the following hypotheses
H
0
: p
1
= p
2
(= p) vs H
1
: p
1
6= p
2
: (22)
Denote by p^
i
the estimate of p
i
in arm i; i = 1; 2. Then under the null hypothesis in (22), from
Proposition 6, we have
p
n(p^
1
  p^
2
)
d
!
1
 
0
(1  p)

Z
1
1
p

 
Z
1
2
p
1  

;
where Z
1
1
and Z
1
2
are independent and are as dened in Proposition 5 (with an added subscript
for each treatment arm). Hence a Wald-type test statistic
(p^
1
  p^
2
)=
s
(1  )v^
1
0;1
+ v^
1
0;2
n(1  )f
0
(1  p^)g
2
(23)
will approximately follow a standard normal distribution. Here v^
1
0;i
are the consistent estimates of
v
1
0;i
as dened in Proposition 4 (with an added subscript for each treatment arm) and the pooled
estimate p^ = (n
1
p^
1
+ n
2
p^
2
)=n.
Our next interest lies in comparing two latency distributions F
0;i
(t) = P (T
ij
 tjT
ij
<1); i =
1; 2. For a two-sample comparison, the statistical test is formulated as
H
0
: F
0;1
= F
0;2
vs H
1
: F
0;1
6= F
0;2
: (24)
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Based on (X
ij
; Æ
ij
); j = 1; : : : ; n, we may estimate F
0;i
by
^
F
0;i
(t) = p^
i
 1
^
F
i
(t);
where
^
F
i
(t) is the estimator for the F
i
based on (5) and p^
i
=
^
F
i
(X
n
i

) is the consistent estimator
for p
i
, the estimated non-cure fraction in the i-th arm.
Denote the pooled conditional distribution by
^
F
0;pool
=
n
1
p^
1
^
F
0;1
+ n
2
p^
2
^
F
0;2
n
1
p^
1
+ n
2
p^
2
:
To test H
0
in (24), we dene a class of test statistics to gauge the discrepancy between the two
empirical distributions
^
F
0;1
() and
^
F
0;2
as follows
W
n
=
p
n

Z
1
0
j
^
F
0;1
(t) 
^
F
0;2
(t)j
r
d
^
F
0;pool
(t)

1
r
; (25)
for r  1, where r = 2 corresponds to the Cramer-von Mises statistic proposed by Li and Feng
(2005) and r =1 corresponds to the Kolmogorov-Smirnov testW
n
= sup
t2[0; ]
p
nj
^
F
0;1
(t) 
^
F
0;2
(t)j.
The following proposition gives the asymptotic distribution of W
n
, under H
0
: F
0;1
= F
0;2
(=
F
0
):
Proposition 9 Assume that n
1
=n! . Then under the null hypothesis in (24),
W
r
n
) X
def
=
Z
1
0
j
~
G(t)j
r
dF
0
(t);
if r <1, and
W
n
) X
def
= sup
t2[0; ]
j
~
G(t)j
if r =1, where the Gaussian process G is (distributionally) uniquely dened by
~
G(t) =
1
p

G
1
(t) 
1
p
1  
G
2
(t)
and where G
i
(); i = 1; 2 are independent Gaussian processes as dened in (39) (with an added
subscript).
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For gaining additional insight into the limiting distribution of X , we take the case of r = 2,
and consider a Loeve type expansion in terms of principal components under H
0
. Specically, we
represent the distribution of the random variable X in Proposition 9 as a mixture of noncentral
chi-squares, which would facilitate the numerical realizations.
By exploiting the independence of G
1
() and G
2
(), we can compute the covariance function
K(s; t) of the Gaussian process G(). Specically,
K(s; t) = EfG(s)G(t)g = 
 1
fa
1
(s; t)C
1
(s; t) + b
1
(s; t)v
1
0;1
  d
1
(s; t)C
1
1
(t)  d
1
(t; s)C
1
1
(s)g
+(1  )
 1
fa
2
(s; t)C
2
(s; t) + b
2
(s; t)v
1
0;2
  d
2
(s; t)C
1
2
(t)  d
2
(t; s)C
1
2
(s)g; (26)
where
a
i
(s; t) = p
 2
i
f
0
(1  p
i
F
0
(t))
0
(1  p
i
F
0
(s))g
 1
;
b
i
(s; t) = (p
i

0
(1  p
i
))
 2
F
0
(t)F
0
(s);
d
i
(s; t) =  (p
2
i

0
(1  p
i
F
0
(t)
0
(1  p
i
))
 1
F
0
(s);
and C
i
(s; t), C
1
i
(s) are as dened in Proposition 5 (with an added subscript) for i = 1; 2. The
following proposition presents the result of the Loeve principal component decomposition of X .
Proposition 10 The distribution for the limiting random variable X can be represented as the
following mixture of noncentral chi-squares
X
D
=
1
X
k=1

k
Z
2
k
; (27)
where Z
k
are i.i.d. standard normal random variables and 
k
are the eigenvalues of a symmetric
compact positive linear operator T on Hilbert space

L
2
([0;1]); (; )

with inner product (f; g) =
R

0
f(s)g(s)F

(ds),
(T f)(t) =
Z
1
0
K(s; t)f(s)F

(ds):
Again, without loss of generality, we may assume that the 
k
are decreasing in k to zero.
The proof is similar to Li and Feng (2005), which was derived when T and U are independent
(i.e. (t) =   log(t)) and is thus omitted.
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7 Numerical Studies
7.1 Real Data Example
We applied the developed methods to analyze the prostate cancer data in SEER Cancer Incidence
Public-Use Database, released on April 2004 based on the November 2003 submission. We focused
on prostate cancer cases in Connecticut and Detroit Metropolitan area diagnosed between year
1973 and 2001 and during the early stages of the disease, where the tumor was still in situ,
localized or regional, excluding cases where the cancer had spread to remote parts of the body.
There were 91,873 such cases, of which 75,615 people were white. The analysis consisted of
estimating the survival fractions, survival curves and latency distributions for the white and non-
white subpopulations, targeting on health disparities. Using the theoretical results of the previous
sections, we tested whether or not the two subpopulations were dierent in these respects.
About 37% of the censored observations were due to death from other causes, with cardiovas-
cular disease (CVD) being the major cause of these deaths. As prostate cancer and CVD share
common risk factor, e.g. high intake of fat, we assumed various strengths of correlation between
time to prostate cancer death and the censoring time. For illustration, we considered both Frank's
and Clayton's families of Archimedean copulas, with the correlation parameter chosen such that
the Kendall's tau ranged from 0 to 0.47. As expected, the point estimates of the cure fraction
varied as the strength of the dependence varied - the weaker the dependence is, the larger the
estimate of the cure fraction is. This indeed has some important implications in evaluation of
the progress made in cancer. With the mortality rate for CVD having a decreasing trend, fewer
censorings would be due to CVD. Assuming a positive dependence between the CVD and the
prostate cancer, we might see that the overall dependence among the prostate cancer death and
the censoring would become weaker as fewer censorings are due to CVD. Hence, the data would
yield a trend of higher cancer cure rates, indicating overall progress against cancer. On the other
hand, if the dependence increases, more deaths that could have resulted from CVD are trans-
ferred to cancer. As a result, we would see a faster decrease in the cure fraction estimates, thus
articially indicating that we are not making decent progress in cancer; though in reality there
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might be a higher true cure rate. Theoretical justications for this phenomenon will be given in
Proposition 11 in the discussion section.
Figure 1 and Table 1 present the estimated cure fractions for the two subpopulations for
an analysis based on Frank's family. Assuming that the censoring mechanisms correspond to
approximately equal values of Kendall's  , the cure fractions for whites are uniformly higher than
those for non-whites. Figure 2 plots the survival curves and the latency distributions for the two
subpopulations. The graphs indicate that the prostate cancer survival rates are higher for whites,
irrespective of the degree of dependence in the censoring mechanism.
Table 2 displays the results for dependent censoring under Frank's family for dierent Kendall's
tau. The rst four columns test the null hypothesis (24) that the latency distribution for whites
(F
0;1
) equals that for non-whites (F
0;2
). Columns 1 and 2 display the Cramer-von Mises test
statistics dened in (25) with the p-values estimated using Proposition 9. The third and fourth
columns present the results for the Kolmogorov-Smirnov test. For tau  0:19, there is no strong
evidence at the 1% signicance level that the latency distributions of whites and non-whites are
dierent. On the other hand, there is strong evidence of a dierence in the latency distributions
if the dependence between the survival time and the censoring is large (e.g. when tau  0:32).
The fth and sixth columns present the results for testing whether whites and non-whites
have the same cure fractions. The theory is developed in section 6.2 and the test statistics
is dened in (23). There is strong evidence that the cure fractions are dierent for the two
subpopulations. Using the theoretical results derived in Section 6.1, we tested whether or not a
cure fraction exists for the entire population. For this, we computed a 95% one-sided condence
interval for  = max
t
fS
T
(t)  S
0
(t)g using all 91,873 cases in the data set. Expression (16) was
used to compute the bounds since the estimated hazard
^

0
() was found to be non-decreasing.
Expression (13) was used to nd suitable choices for t
0
< t
1
by a stochastic search. These
intervals are specied in the last column of Table 1. The lower bounds of the intervals are all
positive implying that there is signicant evidence at the 5% level that a cure fraction exists for
the entire population. Analysis assuming dependent censoring under Clayton's family of copulas
were similar to those obtained under Frank's family and lead to the same conclusions.
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7.2 Simulation Study
We investigated by simulation the nite-sample behavior of the cure fraction estimator, i.e. p^ =
1  
^
S
T
(X
n
). Proposition 6 proves that this estimator is consistent and asymptotically normal,
with (11) specifying its asymptotic variance.
We simulated the survival data by generating independent censoring times U
i
, where i =
1; : : : ; n, from the exponential distribution with hazard rate r (mean 1=r). Conditional on the
censoring times, the failure times X
i
were generated for dependent censoring under Frank's copula
model with various correlation parameter a = 0; 2:1; 5:7, corresponding roughly to Kendal's tau
0; 0:2; 0:47. The latency distribution of the failure times was exponential with mean one and
truncated at 
F
0
= 2. The true cure fraction of the failures was p = 0:3. The rate r in the
censoring distribution was chosen to be 1; 0:5; 0:2, resulting roughly 60%, 40% and 20% censoring
among `non-cured' patients. For each simulated data, the estimate p^ = 1  
^
S
T
(X
n
) was then
computed and its asymptotic variance was computed using (11).
The above steps were repeated for 3,000 replications to obtain estimates of p based on the
3,000 dierent data sets. The empirical variance of p^ was computed and compared with the
average asymptotic variance. Table 3 presents the results for various combination of sample size,
Frank family parameter a and censoring rate r.
For any given (a; r) pair, estimate p^ is found to approach the true value as the sample size
n increases. Additionally, the dierence between the empirical and asymptotic standard errors
tend to zero, and the empirical coverage probabilities of the 95% condence intervals approach the
nominal value of the condence level. These results verify the validity of Proposition 6. For a given
value of dependence parameter a and sample size n, the standard errors decrease with censoring
rate r. This is reasonable because a smaller censoring rate implies stochastically greater censoring
times and a smaller proportion of censored observations, resulting in a more precise estimate of
the cure fraction.
Simulations were also performed to verify the covariance structure derived in (8). In particular,
Table 4 uses the simulated data to verify expression (8) for the covariance between survival
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function estimates at t
1
= 1 and t
2
= 2. For any given (a; r) pair, the empirical covariance
matches well the asymptotic value, especially as n grows.
8 Discussion and Future Work
This paper proposes a mixture cure model which allows dependent censoring. In particular, we
have considered the parameter estimation, the cure detection, and the comparison of latency
distributions in the presence of dependent censoring when a proportion of patients is deemed
cured. The dependence between the survival time and its potential censoring time is modeled
using a class of Archimedean copula models with a known  function. In practice, however,
selecting a right  function in the copula is often hampered by the fact that with the current data
on (X; Æ), the copula model is not identiable (Tsiatis, 1978). In some applications where both
the censoring and failure times were observed for a sub-sample (Bartholomew, 1957), a suitable
copula function could be identied with this additional information. Hence, the estimation of cure
models incorporating, in the framework outlined in this article, an assessment of the dependence
between the censoring and failure times appears to be a promising research area; some related
work can be found in Lin et al. (1996) and Wang (2003).
Additionally, based on the analytical framework we have set up it would be feasible to con-
duct bias analysis when the dependence structure between survival and censoring times are mis-
specied. In particular, we can quantify the biases in the estimates of cure fractions for such
misspecications.
Using the same argument in Proposition 1, we can show that for any  function (which satises
the regularity conditions (c.1)-(c.5)), the estimate based on (5) converges uniformly to
S

T
(t) = 
 1

 
Z
t
0

0
f(s)g(s)d
~
(s)

:
When  is misspecied, S

T
may not be equal to S
T
, the true survival function. Hence the estimate
of cure converges to (1   p

) = lim
t!
X
S

T
(t), which may not be equal to the true cure fraction
1  p = lim
t!
X
S
T
(t). Analogous to Corollary 6.1 of Zheng and Kelin (1996) and Proposition 2
of Rivest and Wells (2001), the following proposition concerns the asymptotic impact of changing
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the level of dependency between T and U on estimating the cure fractions.
Proposition 11 Let 
1
and 
2
be two functions used in (5). If 
0
1
(t)=
0
2
(t) increases in t then
the asymptotic limit of cure fraction 1  p

1
 1  p

2
.
Indeed Proposition 11 follows from Proposition 2 of Rivest and Wells (2001) by taking t !

X
. Genest and MacKay (1986) showed that 
0
1
(t)=
0
2
(t) " t implies that 
1
corresponds to
less dependence between T and U than 
2
under (3). Thus Proposition 11 reveals that, under
undetected positive dependence between T and U , failing to account for such dependence (e.g.
the Kaplan Meier estimate of cure fraction proposed by Maller and Zhou (1992)) will tend to over-
estimate the true cure fraction. On the other hand, if there exists negative dependence between
T and U , a naive Kaplan-Meier estimate will under-estimate the true cure fraction.
9 Acknowledgements
The rst author thanks Professors David Harrington and Robert Gray for helpful comments.
Appendix: Technical Details
A.0: Regularity Conditions
We impose the following regularity conditions on S
T
(t) (or F
T
(t)), (t) and the copula function
.
(c.1)  is strictly decreasing on (0; 1] and is suÆciently smooth. Further assume that the rst two
derivatives of (s) and  (s)
def
=  s
0
(s) are bounded for s 2 [; 1] where  > 0 is arbitrary.
In addition, the rst derivative of (s) is bounded away from 0 on [0; 1].
(c.2) 0 <
R

X
0
f ((s))g
k
d
~
(s) <1 for k = 0; 1; 2
(c.3)
R

X
0
j( 
0
((s))jd
~
(s) <1
(c.4) lim sup
t!
X
R

X
t
( ((s))
2
(s)
d
~
(s) = 0
(c.5) S
T
(t) and S
0
(t) are continuous over [0; 
X
] if 
X
< 1. Otherwise, dene S
T
(1) =
lim
t!1
S
T
(t).
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A.1: Proof of Proposition 1
First show that for any xed t
0
such that (t
0
) > 0;
sup
t2[0;t
0
]
j(
^
S
T
(t))  (S
T
(t))j
pr:
! 0:
A Taylor expansion and the regularity condition (c.1) on  gives, on [0; t
0
],
(
^
S
T
(t)) =  
Z
t
0
1
n

0

Y (s)
n

dN(s) + e
n
;
where e
n
= o
p
(1) uniformly over [0; t
0
]. Some algebra yields
(S
T
(t)) =  
Z
t
0

0
((s))(s)d
~
(s):
Hence,
(
^
S
T
(t))  (S
T
(t))
=  
1
n
Z
t
0
I(Y (s) > 0)
0

Y (s)
n

dM(s) +
Z
t
0
I(Y (s) > 0)

 

Y (s)
n

   ((s))

d
~
(s)
 
Z
t
0
I(Y (s) = 0)
0
((s))(s)d
~
(s) + e
n
= Z
1
(t) + Z
2
(t) + Z
3
(t) + e
n
;
where M(s) =
P
n
i=1
M
i
(s) is a martingale.
When t 2 [0; t
0
],
0 < Z
3
(t)  I(Y (t) = 0)
Z
t
0
 ((s))d
~
(s)
< I(Y (t
0
) = 0)
Z

X
0
 ((s))(s)d
~
(s):
By the strong law of large numbers Y (t
0
)=n ! (t
0
)(> 0) almost surely. Hence Y (t
0
) !
1 almost surely. From this, coupled with the regularity condition (c.2), we have the uniform
convergence of Z
3
(t) over [0; t
0
]. It remains to demonstrate the convergence of Z
1
(t) and Z
2
(t).
Consider the variation process of Z
1
(t),
< Z
1
; Z
1
> (t) =
Z
t
0
I(Y (s) > 0)


0

Y (s)
n

2
Y (s)
n
2
d
~
(s)
=
Z
t
0
I(Y (s) > 0)
Y (s)

 

Y (s)
n

2
d
~
(s):
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Then it follows that Z
2
1
(t)  < Z
1
; Z
1
> (t) is a martingale. By Lenglart's inequality ( see, e.g.,
Fleming and Harrington (1991))
P ( sup
t2[0;t
0
]
jZ
1
(t)j > )
<


2
+ P (
Z
t
0
0
I(Y (s) > 0)
Y (s)
( (
Y (s)
n
))
2
d
~
(s) > )
<


2
+ P

1
Y (t
0
)
Z
t
0
0
( (
Y (s)
n
))
2
d
~
(s) > 

:
Since the empirical process
Y (s)
n
! (s) in probability uniformly on [0;1) and because of the
boundness regularity conditions on  () and  
0
() on [(t
0
); 1],  
2
(
Y (s)
n
) converges to  
2
((s))
unformly on [0; t
0
].
Hence
R
t
0
0
( (
Y (s)
n
))
2
d
~
(s) !
R
t
0
0
( ((s))
2
d
~
(s) <1 (by the regularity condition (c.2) ). So
1
Y (t
0
)
R
t
0
0
( (
Y (s)
n
))
2
d
~
(s)
pr
! 0 as Y (t
0
)
pr
!1. Hence, P (sup
0tt
0
jZ
1
(t)j > )! 0 for any  > 0.
Now consider
Z
2
(t) =
Z
t
0
I(Y (s) > 0) 
0
((s))

Y (s)
n
  (s)

d
~
(s) + e
n
where e
n
= o
p
(1=n) uniformly on [0; t
0
]. Further note that
sup jZ
2
(t)j  sup je
n
j+

Z
t
0
0
j 
0
((s))jd
~
(s)

sup
0st
0
j
Y (s)
n
  (s))j;
which implies (under the regularity condition (c.3)) that
sup
0tt
0
jZ
2
(t)j
pr:
! 0:
Thus we have proved that
sup
0tt
0
j(
^
S
T
(t))  (S
T
(t))j
pr:
! 0
for any t
0
such that (t
0
) > 0.
Now we show that
sup
0t
X
j(
^
S
T
(t))  (S
T
(t))j
pr:
! 0:
We only consider the situation when 
X
<1 as the proof follows similarly when 
X
=1. Fix a
small  > 0 and consider any t 2 [
X
  ; 
X
]. With monotonicity of S
T
and , it follows that
j(
^
S
T
(t))  (S
T
(t))j
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< j(
^
S
T
(
X
))  (
^
S
T
(
X
  ))j+ j(
^
S
T
(   ))  (S
T
(
X
  ))j
+j(S
T
(
X
  ))  (S
T
(
X
))j:
Also note that
sup
0t
X
j(
^
S
T
(t))  (S
T
(t))j
 sup
0t
X
 
j(
^
S
T
(t))  (S
T
(t))j+ sup

X
 t
X
j(
^
S
T
(t))  (S
T
(t))j
 sup
0t
X
 
j(
^
S
T
(t))  (S
T
(t))j+ j(
^
S
T
(
X
))  (
^
S
T
(
X
  ))j+ j(
^
S
T
(   ))  (S
T
(
X
  ))j
+j(S
T
(
X
  ))  (S
T
(
X
))j:
Using the uniform convergence of
^
S
T
(t) on [0; 
X
  ] and letting ! 0+ yields
sup
0t
X
j(
^
S
T
(t))  (S
T
(t))j
pr:
! 0:
As 
0
() is bounded away from 0 on [0; 1] (condition c.1), a Taylor expansion immediately yields
sup
0t
X
j
^
S
T
(t)  S
T
(t)j
pr:
! 0:
Applying a similar argument, we may demonstrate the uniform convergence of
R
t
0
I(Y (s) >
0)
dN
Y
to
~
(t) on [0; 
X
] by observing that
Z
t
0
I(Y (s) > 0)
dN
Y
 
Z
t
0
d
~
(s) =
Z
t
0
I(Y (s) > 0)
dM
Y
 
Z
t
0
I(Y (s) = 0)d
~
(s):
A.2: Proof of Proposition 2
By the denition of 
X
, X
n
! 
X
almost surely. Consider
j(
^
S
T
(X
n
))  (S
T
(
X
))j
 j(
^
S
T
(X
n
))  (S
T
(X
n
))j+ j(S
T
(X
n
))  (S
T
(
X
))j
 sup
0t
X
j(
^
S
T
(t))  (S
T
(t))j+ j(S
T
(X
n
))  (S
T
(
X
))j
Hence by the uniform convergence of (
^
S
T
(t)) and continuity of S
T
(t) at 
X
, we have
^
S
T
(X
n
)
pr:
!
S
T
(
X
). So
^
S
T
(X
n
)
pr:
! (1 p) if and only if S
T
(
X
) = (1 p). Since 
F
0
= supft : S
T
(t) > 1 pg,
it then follows that S
T
(
X
) = (1  p) if and only if 
F
0
 
X
.
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A.3: Proof of Proposition 3
Since (t)  S
U
(t), hence ft : (t) > 0g  ft : S
U
(t) > 0g, yielding 
X
 
U
.
On the other hand, we can also show that 
U
 
X
. Indeed we only need to consider the case
when 
X
<1. Otherwise the inequality holds trivially. Specically, when 
X
 1, (
X
+) = 0
and therefore ((
X
+)) =1. Under (3),
(S
T
(
X
+)) + (S
U
(
X
+)) = ((
X
+));
and as p < 1, S
T
(
X
+)  S
T
(1) = 1   p > 0. So (S
T
(
X
+)) < 1. Hence (S
U
(
X
+)) = 1,
which implies that S
U
(
X
+) = 0. By the denition of 
U
= supft : S
U
(t) > 0g, it follows 
U
 
X
.
A.4: Proof of Proposition 4
We rst show by contradiction that if 
n
! 0 in probability (or equivalently N
n
!1 in proba-
bility), then 
F
0
< 
U
. Otherwise, if we assume 
U
 
F
0
, we show that N
n
does not converge to
1 in probability, which induces a contradiction.
Choose a constant b > 0 such that
1
b
+ e
 b=M
<
1
2
. Dene a
n
= inffa : h(2a) 
b
n
g. By
the condition (d.1), a
n
is well dened (or at least for large n), a
n
# 0 and h(2a
n
) =
b
n
by the
continuity of h. Dene an event A
n
= fX
n
> 

  a
n
g. The key idea of the proof is to show A
n
happens with a large probability, while on A
n
, N
n
is bounded with a large probability, resulting
in a contradiction.
Indeed
P (A
n
) = P (X
n
> 

  a
n
) = Pf[
n
i=1
(U
i
 T
i
> 

  a
n
)g:
By independence across the subjects
P (A
c
n
) =
Y
Pf(U
i
 T
i
> 

  a
n
)
c
g = (1  h(a
n
))
n
 (1  h(2a
n
)=M)
b
 e
 b=M
:
By assumption 
U
 
F
0
, we have X
n
 X
n
 

def
= 
U
^ 
F
0
= 
U
almost surely. Further-
more, on A
n
we have 

  a
n
 X
n
 X
n
  , whence,
[2X
n
 X
n
;X
n
]  [

  2a
n
; 

]:
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Dene indicator Y
in
= I(

  2a
n
 X
i
 

; Æ
i
= 1). As N
n
is the number of uncensored
observations on [2X
n
 X
n
;X
n
], it follows that if A
n
happens, then N
n

P
i
Y
in
. Thus
E(Y
in
) = P (

  2a
n
 T
1
 U
1
 

) = h(2a
n
) =
b
n
:
and var(Y
in
)  E(Y
2
in
) = E(Y
in
) =
b
n
.
Therefore, by Chebyshev's inequality
P (N
n
> 2b)  P (N
n
> 2b;A
n
) + P (A
c
n
)
 P (
X
Y
in
> 2b;A
n
) + P (A
c
n
)
 P (
X
Y
in
> 2b) + e
 b=M
 P (
X
(Y
in
  b=n) > b) + e
 b=M

nvar(Y
1n
)
b
2
+ e
 b=M

1
b
+ e
 b=M
< 1=2:
This contradicts with that N
n
! 1 in probability. Hence the assumption 
U
 
F
0
must not
hold, and we must have 
F
0
< 
U
:
Now we show the converse is true. That is, 
F
0
< 
U
implies N
n
!1 in probability. Indeed,
X
n
! 
F
0
and X
n
! 
U
almost surely. Hence for any xed  > 0

F
0
    X
n
 
F
0
 
U
    X
n
 
U
;
with probability 1 when n is suÆciently large.
Therefore, with probability 1,
[

   + ; 

]  [2X
n
 X
n
;X
n
];
where 

= 
F
0
^ 
U
= 
F
0
and  = 
U
  
F
0
. Let Z
i
= I(

   +   X
i
 

; Æ
i
= 1). Then
N
n

P
i
Z
i
almost surely.
But
E(Z
i
) =
Z




 +
(t)d
~
(t) = h(   ):
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So if we take  <    
0
, we have E(Z
i
) > h(
0
) > 0 (by the condition (d.1)). Therefore the law
of large numbers gives
P
i
Z
i
=n ! E(Z
i
) > 0 in probability. Hence
P
i
Z
i
! 1 in probability,
which indicates N
n
!1 in probability.
A.5: Proof of Proposition 5
Using the same argument as in Rivest and Wells (2001), up to an o
p
(1) term, we have that
Z
n
(t) =
p
n

 
1
n
Z
t^X
n
0
I(Y (s) > 0)
0

Y (s)
n

dM(s)
+
Z
t^X
n
0
I(Y (s) > 0)

 

Y (s)
n

   ((s)

d
~
(s)

= Z
n;1
(t) + Z
n;2
(t): (28)
Rivest and Wells (2001) showed, for any t
0
such that (t
0
) > 0, Z
n
(t) converges weakly to
Z(t) on D[0; t
0
]. To show the weak convergence of Z
n
(t) on D[0; 
X
], it is suÆcient to show the
tightness of Z
n
(t) in a small (left) neighborhood of 
X
in view of Theorems 13.2 and 16.8 of
Billingsley (1999). That is, it suÆces to show for any  > 0
lim
t!
X
lim sup
n
P ( sup
s2(t;
X
]
jZ
n
(s)  Z
n
(t)j > ) = 0; (29)
see, also, Gill (1980).
Fix a t. Then
sup
s2(t;
X
]
jZ
n
(s)  Z
n
(t)j  sup
s2(t;
X
]
jZ
n;1
(s)  Z
n;1
(t)j+ sup
s2(t;
X
]
jZ
n;2
(s)  Z
n;2
(t)j:
Since X
n
is a stopping time, and by the optional sampling theorem,
Z
n;1
(s)  Z
n;1
(t) =  
1
p
n
Z
s^X
n
t^X
n
I(Y (s) > 0)
0

Y (s)
n

dM(s)
is a local martingale and its predictable variation process is given by
< Z
n;1
(s)  Z
n;1
(t); Z
n;1
(s)  Z
n;1
(t) >=
Z
s^X
n
t^X
n
I(Y (s) > 0)

 

Y (s)
n

2
n
Y (s)
d
~
(s);
hence,
(Z
n;1
(s)  Z
n;1
(t))
2
  < Z
n;1
(s)  Z
n;1
(t); Z
n;1
(s)  Z
n;1
(t) >
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is a martingale (again assume that t is xed).
Therefore, by Lenglart's inequality we have
P ( sup
[t;
X
]
jZ
n;1
(s)  Z
n;1
(t)j > )
<


2
+ P (
Z

X
^X
n
t^X
n
I(Y (s) > 0)

 

Y (s)
n

2
n
Y (s)
d
~
(s) > )



2
+ P (
Z

X
t

 

Y (s)
n

2
n
Y (s)
d
~
(s) > ): (30)
Because of the uniform convergence of
Y (s)
n
to (s) on [0; 
X
],
Z

X
t

 

Y (s)
n

2
n
Y (s)
d
~
(s)
pr:
!
Z

X
t
( ((s))
2
(s)
d
~
(s);
for any t < 
X
. Hence by the regularity condition (c.4), the second term in (30) converges to 0
for any  > 0 as t! 
X
. Hence, we have
lim
t!
X
lim sup
n
P ( sup
[t;
X
]
jZ
n;1
(s)  Z
n;1
(t)j > ) = 0: (31)
Now we turn to show that
lim
t!
X
lim sup
n
P ( sup
[t;
X
]
jZ
n;2
(s)  Z
n;2
(t)j > ) = 0: (32)
As
Z
n;2
(s)  Z
n;2
(t) =
Z
s^X
n
t^X
n
I(Y (s) > 0) 
0
((s))
p
n

Y (s)
n
  (s)

d
~
(s) + o
p
(1);
it follows that (32) holds as
p
n(
Y (s)
n
  (s)) converges weakly to a tight Gaussian process over
[0;1). Combining (31) and (32) gives (29). Hence the proposition follows.
For completeness we compute below the covariance function for the limiting process Z(t),
which is needed in computing the asymptotic distribution of the test statistic derived later. The
derivation of this covariance function, which is not given in Rivest and Wells (2001), is involved
as Z(t) is not an independent increment process.
For any t < 
X
, as X
n
! 
X
almost surely and following Rivest and Wells (2001), we can
show that (28) is asymptotically equal to (up to an o
p
(1) term)
W
n
(t) =
1
p
n
Z
t
0
 
0
((u))dM(u) +
Z
t
0
X
n
(s) 
0
((s))d
~
(s) =W
n;1
(t) +W
n;2
(t);
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where X
n
(s) =
p
n
n
Y
n
(s)
n
  (s)
o
. Hence we only need to compute the limiting covariance
function for W
n
(t).
Consider 0  t
1
 t
2
 
X
. Then
covfW
n
(t
1
);W
n
(t
2
)g = EfW
n;1
(t
1
)W
n;1
(t
2
)g+EfW
n;2
(t
1
)W
n;2
(t
2
)g
+EfW
n;1
(t
1
)W
n;2
(t
2
)g+EfW
n;1
(t
2
)W
n;2
(t
1
)g:
Since W
n;1
() is a square integrable martingale,
EfW
n;1
(t
1
)W
n;1
(t
2
)g =
1
n
E

Z
t
1
0
[
0
f(s)g]
2
Y (s)d
~
(s)

=
Z
t
1
0
[
0
f(s)g]
2
(s)d
~
(s):
Also
EfW
n;2
(t
1
)W
n;2
(t
2
)g
= E
Z
t
2
0
Z
t
1
0
(Y
1
(u)  (u))(Y
1
(s)  (s)) 
0
((u))d
~
(u) 
0
((s))d
~
(s)
= E
Z
t
1
0
Z
t
1
0
(Y
1
(u)  (u))(Y
1
(s)  (s)) 
0
((u))d
~
(u) 
0
((s))d
~
(s)
+E
Z
t
2
t
1
Z
t
1
0
(Y
1
(u)  (u))(Y
1
(s)  (s)) 
0
((u))d
~
(u) 
0
((s))d
~
(s)
= 2
Z
t
1
0
Z
s
0
(s)(1  (u)) 
0
((u))d
~
(u) 
0
((s))d
~
(s)
+
Z
t
2
t
1
(s) 
0
((s))d
~
(s)
Z
t
1
0
(1  (u)) 
0
((u))d
~
(u);
where the calculation of E
R
t
1
0
R
t
1
0
comes from Rivest and Wells (2001) (after correcting a typo-
graphic error in their formula).
IntroduceA(s) =  
0
((s)) andB(s)ds =  
0
((s))d
~
(s). Applying the result E(M
1
(u)Y
1
(s)) =
 (s)
~
(u ^ s) and integration by parts, we have
covfW
n;2
(t
1
);W
n;1
(t
2
)g
= E

Z
t
1
0
A(u)dM
1
(u)
Z
t
2
0
(Y
1
(s)  (s))B(s)ds

= E

Z
t
2
0
A(t
1
)M
1
(t
1
)Y
1
(s)B(s)ds

(33)
+E

Z
t
2
0
Z
t
1
0
 M
1
(u)Y
1
(s)dA(u)B(s)ds

(34)
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Using
R
t
2
0
=
R
t
1
0
+
R
t
2
t
1
, (33) is
 
~
(t
1
)
Z
t
1
0
(s)
~
(s)B(s)ds 
~
(t
1
)A(t
1
)
Z
t
2
t
1
(s)B(s)ds (35)
while using
R
t
2
0
R
t
1
0
=
R
t
1
0
R
t
1
0
+
R
t
2
t
1
R
t
1
0
, (34) is
Z
t
1
0
Z
t
1
0
(s)
~
(u ^ s)dA(u)B(s)ds+
Z
t
2
t
1
Z
t
1
0
(s)
~
(u)dA(u)B(s)ds: (36)
Adding the rst term of (35) and the rst term of (36) gives  
R
t
1
0
R
s
0
A(u)d
~
(u)(s)B(s)ds
following Rivest and Wells (2001, though a minus sign is missing in their formulation). Integration
by parts with respect to dA(u) in the second term of (36) gives the summation of the second term
in (35) and the second term in (36) is
 
Z
t
2
t
1
(s)B(s)ds
Z
t
1
0
A(u)d
~
(u)
So,
covfW
n;1
(t
1
);W
n;2
(t
2
)g =  
Z
t
1
0
Z
s
0
A(u)d
~
(u)(s)B(s)ds 
Z
t
2
t
1
(s)B(s)ds
Z
t
1
0
A(u)d
~
(u):
(37)
Similarly we obtain
covfW
n;1
(t
2
);W
n;2
(t
1
)g =  
Z
t
1
0
Z
s
0
A(u)d
~
(u)(s)B(s)ds: (38)
Plugging back A(u) =  
0
((s)) and B(s)ds =  
0
((s))d
~
(s) in (37) and (38) and using the
weak convergence of a tight process W
n
to Z(t), we have thus obtained the covariance function
C(t
1
; t
2
) as stated in the proposition.
A.6: Proof of Proposition 6
Note that
p
nf(1  p^)  (1  p)g =
p
nf(
^
S
T
(X
n
))  (S
T
(X
n
))g+
p
nf(S
T
(X
n
))  (1  p)g
= Z
n
(
X
) +
p
nf(S
T
(X
n
))  (1  p)g
where Z
n
(
X
), as dened in (7), converges weakly to Z
1
by Proposition (5).
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We only need to show
p
nf(S
T
(X
n
)) (1 p)g
pr:
! 0. For a xed  > 0, consider an increasing
sequence a
n
such that
F
0
(a
n
 )  1 

p
np
 F
0
(a
n
):
It follows that a
n
! 
F
0
, where 
F
0
is the right extreme of F
0
. Thus
P (
p
njp  F (X
n
)j > ) = P (
p
njp  pF
0
(X
n
)j > ) = P (X
n
 a
n
):
Assume (9), which implies that the tail of the observed survival times is heavier than that
of the latency distribution. Indeed when 
F
0
< 
X
(= 
U
) this assumption holds immediately as
lim
t!
F
0
1 F
0
(t)
(t)
= 0. Under assumption (9) we have (t)  1  F
0
(t) when t is suÆciently close
to 
F
0
. Hence when n is suÆciently large
P (X
n
 a
n
) = (1  (a
n
))
n
 (1 

p
np
)
n
! 0:
Thus,
p
njp  F (X
n
)j converges to 0 in probability and so does
p
nj(1  p)  (S
T
(X
n
))j to
0 by the boundedness condition on 
0
() (the regularity condition (c.1)). Therefore (10) holds,
which also implies (11) by the Slutsky theorem.
A.7: Proof of Proposition 7
Note that
sup
[0;
X
]
j
^
F
0
(t)  F
0
(t)j 
1
p^
sup
[0;
X
]
j
^
S
T
(t)  S
T
(t)j+
1
pp^
jp^  pj:
Hence the result follows as
^
S
T
(t) converges to S
T
(t) uniformly on [0; 
X
] coupled with p^  p
pr:
! 0.
A.8: Proof of Proposition 8
First observe that
p
nf
^
F
0
(t ^X
n
)  F
0
(t ^X
n
)g
=
p
n
(
^
F
T
(t ^X
n
)
p^
 
F
T
(t ^X
n
)
p
)
=
 
p
nf(
^
S
T
(t ^X
n
)  (S
T
(t ^X
n
))g
p
0
(S
T
(t ^X
n
))
 
1  S
T
(t ^X
n
)
p
2
p
n(p^  p) + o
p
(1):
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Now since
p
nf(
^
S
T
(t^X
n
) (S
T
(t^X
n
))g
w
! Z(t) on D[0; 
X
] (Proposition 5) in conjunction
with
p
n(p^ p)
d
!
Z
1
 
0
(1 p)
and X
n
! 
X
almost surely, it follows that
p
nf
^
F
0
(t) F
0
(t)g
w
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on D[0; 
X
), where
G(t) =  
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p
0
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T
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+
f1  S
T
(t)gZ
1
p
2

0
(1  p)
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A.9: Proof of Proposition 9
Denote by X
n
= X
n
1
^X
n
2
and dene residual processes 
n
i
(t) =
p
n
i
f
^
F
0;i
(t^X
n
) F
0
(t^X
n
)g.
The sample paths of stochastic processes 
n
i
reside in the Skorohod spaceD
R
[0;  ]. Then it follows
by Proposition 8) 
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(t): Hence by the continuous mapping theorem, when r <1
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Figure 1: Estimated prostrate cancer cure fractions for whites (Æ) and non-whites () under
Frank's family of copulas. The lines represent margins of two standard errors.
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Figure 2: Summary of prostrate cancer results for Archimedean copulas based on Frank's family.
The unbroken lines correspond to whites and the dashed lines to non-whites. The top panels
graph the survival curves for Kendall's tau equal to 0 and 0.32. The bottom panels graph the
latency distributions.
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Whites Non-whites
 Estimate SE Estimate SE
0 0.55 0.015 0.49 0.039
0.01 0.55 0.015 0.48 0.039
0.03 0.50 0.015 0.43 0.039
0.09 0.50 0.015 0.43 0.039
0.12 0.44 0.015 0.37 0.038
0.16 0.39 0.015 0.32 0.035
0.19 0.39 0.015 0.32 0.035
0.32 0.30 0.013 0.25 0.030
0.42 0.22 0.010 0.18 0.023
0.47 0.20 0.010 0.16 0.021
Table 1: Cure fractions based on Frank's family of Archimedean copulas.
 CvM Test P-Value K-S Test P-Value Wald z P-Value 95% CI for 
0 27.79 0.26 15.97 0.06 -3.04 0.00 ( 0.195 ,1)
0.01 27.67 0.25 15.94 0.06 -3.04 0.00 ( 0.195 ,1)
0.03 23.18 0.26 14.28 0.07 -2.93 0.00 ( 0.198 ,1)
0.09 23.18 0.26 14.28 0.07 -2.93 0.00 ( 0.198 ,1)
0.12 24.51 0.19 12.53 0.08 -2.94 0.00 ( 0.198 ,1)
0.16 30.74 0.09 11.44 0.07 -3.05 0.00 ( 0.196 ,1)
0.19 30.74 0.10 11.44 0.09 -3.05 0.00 ( 0.194 ,1)
0.32 48.01 0.01 13.04 0.01 -3.47 0.00 ( 0.177 ,1)
0.42 66.24 0.00 13.47 0.00 -4.31 0.00 ( 0.148 ,1)
0.47 69.82 0.00 13.42 0.00 -4.59 0.00 ( 0.137 ,1)
Table 2: Results based on Frank's family of Archimedean copulas.
38
Hosted by The Berkeley Electronic Press
a r n p^ Empirical SE Asymptotic SE 95% C.I. Coverage
0 1 50 0.311792 0.1140858 0.0981302 0.865
0 1 100 0.3035328 0.08593271 0.07637336 0.903
0 1 500 0.3013318 0.03856888 0.03702753 0.936
2.1 1 50 0.3086511 0.1049240 0.09002797 0.878
2.1 1 100 0.3049256 0.07592004 0.06883757 0.908
2.1 1 500 0.3008560 0.03328404 0.0322699 0.939
5.7 1 50 0.3154014 0.1001547 0.08272287 0.882
5.7 1 100 0.309741 0.06823369 0.06206997 0.910
5.7 1 500 0.3025891 0.02880224 0.02869691 0.949
0 0.5 50 0.2999443 0.08688357 0.08017418 0.908
0 0.5 100 0.2985752 0.06125795 0.05896112 0.935
0 0.5 500 0.2998565 0.02743993 0.02707487 0.942
2.1 0.5 50 0.3032127 0.07910919 0.07369643 0.919
2.1 0.5 100 0.2989564 0.0569155 0.05332041 0.924
2.1 0.5 500 0.3007000 0.0242311 0.02439310 0.953
5.7 0.5 50 0.3027497 0.06907557 0.06668318 0.938
5.7 0.5 100 0.3011927 0.04985439 0.04809085 0.935
5.7 0.5 500 0.3003604 0.0215772 0.02184662 0.950
0 0.2 50 0.3001357 0.07285168 0.06916037 0.927
0 0.2 100 0.3006226 0.0506231 0.0501023 0.942
0 0.2 500 0.2998538 0.02258296 0.02277172 0.952
2.1 0.2 50 0.2996179 0.06919427 0.06588285 0.932
2.1 0.2 100 0.2985278 0.04925562 0.04750322 0.936
2.1 0.2 500 0.2995015 0.02154124 0.02160814 0.946
5.7 0.2 50 0.3028895 0.06584249 0.06286433 0.930
5.7 0.2 100 0.2988817 0.04722508 0.04532081 0.931
5.7 0.2 500 0.2993998 0.02109654 0.02064824 0.943
Table 3: Summary of simulation results investigating the asymptotic behavior of estimator p^ =
1 
^
S
T
(X
n
). The true cure fraction was assumed to be p = 0:3.
39
http://biostats.bepress.com/harvardbiostat/paper26
a r n
^
S
T
(t
1
= 1)
^
S
T
(t
2
= 2) Empirical Cov Asymptotic Cov
0 1 50 0.4970387 0.3155806 0.004653271 0.005108764
0 1 100 0.4872239 0.2907100 0.001973786 0.002541864
0 1 500 0.4904664 0.3000590 0.000481298 0.0005433187
2.1 1 50 0.4914768 0.2936169 0.004572677 0.004072854
2.1 1 100 0.4904447 0.3107039 0.001998270 0.002214692
2.1 1 500 0.4949633 0.3044195 0.0005302537 0.0004365148
5.7 1 50 0.5033339 0.3184996 0.002683341 0.003344544
5.7 1 100 0.4854107 0.3039750 0.002001305 0.001674436
5.7 1 500 0.4882282 0.3029674 0.0003851077 0.0003236679
0 0.5 50 0.4856533 0.2982809 0.003532756 0.003786317
0 0.5 100 0.4885342 0.3023957 0.001884913 0.001975122
0 0.5 500 0.4871333 0.3004378 0.0004329692 0.0004030368
2.1 0.5 50 0.4933665 0.3090195 0.003304896 0.003379181
2.1 0.5 100 0.4914137 0.2998028 0.001809866 0.001710108
2.1 0.5 500 0.4852423 0.3003169 0.0003670738 0.0003549008
5.7 0.5 50 0.4997257 0.3082358 0.003449204 0.002844627
5.7 0.5 100 0.4870287 0.3060905 0.001472245 0.001519335
5.7 0.5 500 0.5007257 0.3022358 0.0003249204 0.0002944627
0 0.2 50 0.4902883 0.3038794 0.003792067 0.003259159
0 0.2 100 0.4833 0.2938062 0.001939279 0.001637402
0 0.2 500 0.4873104 0.2995824 0.0002964434 0.0003404564
2.1 0.2 50 0.4880728 0.2976328 0.003246520 0.00301053
2.1 0.2 100 0.4860294 0.2979742 0.001349038 0.001563168
2.1 0.2 500 0.4853753 0.2998419 0.000429316 0.0003221655
5.1 0.2 50 0.4862388 0.2987405 0.003476443 0.002784509
5.1 0.2 100 0.4871271 0.3011671 0.001435091 0.001484796
5.1 0.2 500 0.4897375 0.3021698 0.0003097326 0.0003086277
Table 4: Summary of simulation results verifying the covariance expression (8) for
cov(
^
S
T
(1);
^
S
T
(2)). The true values S
T
(1) = 0:4882 and S
T
(2) = 0:3.
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